We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+13.06%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$8.1B
AUM Growth
+$4.9B
Cap. Flow
+$4.22B
Cap. Flow %
52.11%
Top 10 Hldgs %
26.76%
Holding
6,444
New
505
Increased
3,426
Reduced
1,637
Closed
524

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$314M
2
AAPL icon
Apple
AAPL
+$247M
3
MSFT icon
Microsoft
MSFT
+$235M
4
AMZN icon
Amazon
AMZN
+$110M
5
NVDA icon
NVIDIA
NVDA
+$99M

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$21.7M
2
VNQ icon
Vanguard Real Estate ETF
VNQ
+$13.8M
3
SPLV icon
Invesco S&P 500 Low Volatility ETF
SPLV
+$12.8M
4
USO icon
United States Oil Fund
USO
+$12.5M
5
IBB icon
iShares Biotechnology ETF
IBB
+$12M

Sector Composition

Rank Sector Weight
1 Technology 26.14%
2 Financials 11.29%
3 Healthcare 10.69%
4 Consumer Discretionary 10.28%
5 Industrials 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DCGO icon
2701
DocGo
DCGO
$64.5M
$93.1K ﹤0.01%
16,646
+10,738
+182% +$61.7K
LUCK
2702
Lucky Strike Entertainment
LUCK
$937M
$93K ﹤0.01%
6,568
+6,352
+2,941% +$69.8K
DSKE
2703
DELISTED
Daseke, Inc. Common Stock
DSKE
$93K ﹤0.01%
11,476
+1,521
+15% +$7.36K
OLP
2704
One Liberty Properties
OLP
$523M
$92.7K ﹤0.01%
4,233
+3,786
+847% +$75.5K
ELAN icon
2705
Elanco Animal Health
ELAN
$11.1B
$92.6K ﹤0.01%
6,212
+3,906
+169% +$44.2K
AVIR icon
2706
Atea Pharmaceuticals
AVIR
$405M
$92.5K ﹤0.01%
30,340
+17,042
+128% +$51.6K
ATMU icon
2707
Atmus Filtration Technologies
ATMU
$4.06B
$92.4K ﹤0.01%
3,933
+2,880
+274% +$61.8K
TARS icon
2708
Tarsus Pharmaceuticals
TARS
$3.07B
$92.3K ﹤0.01%
4,560
+824
+22% +$13.8K
LESL icon
2709
Leslie's
LESL
$7.21M
$92.3K ﹤0.01%
668
-900
-57% -$99K
CSV icon
2710
Carriage Services
CSV
$535M
$92.2K ﹤0.01%
3,688
+897
+32% +$21.1K
CCCC icon
2711
C4 Therapeutics
CCCC
$502M
$92.2K ﹤0.01%
16,322
+4,063
+33% +$9.26K
SPHB icon
2712
Invesco S&P 500 High Beta ETF
SPHB
$956M
$92.1K ﹤0.01%
1,118
+1,075
+2,500% +$77.5K
AKRO
2713
DELISTED
Akero Therapeutics
AKRO
$92.1K ﹤0.01%
3,944
+2,898
+277% +$57.2K
EVGO icon
2714
EVgo
EVGO
$519M
$92K ﹤0.01%
25,702
+21,701
+542% +$64.3K
SKF icon
2715
ProShares UltraShort Financials
SKF
$10.4M
$91.8K ﹤0.01%
1,560
-5,089
-77% -$360K
SVRA icon
2716
Savara
SVRA
$1.08B
$91.7K ﹤0.01%
19,507
+16,959
+666% +$65K
BOC icon
2717
Boston Omaha
BOC
$436M
$91.6K ﹤0.01%
5,824
+5,220
+864% +$79.2K
RDFN
2718
DELISTED
Redfin
RDFN
$91.5K ﹤0.01%
8,864
+4,474
+102% +$31.2K
REFI
2719
Chicago Atlantic Real Estate Finance
REFI
$268M
$91.1K ﹤0.01%
5,629
+4,693
+501% +$71.6K
BEP icon
2720
Brookfield Renewable
BEP
$10.3B
$91K ﹤0.01%
3,464
+2,461
+245% +$58.3K
AVA icon
2721
Avista
AVA
$3.23B
$91K ﹤0.01%
2,547
-1,327
-34% -$45K
TREE icon
2722
LendingTree
TREE
$444M
$90.8K ﹤0.01%
2,995
+1,321
+79% +$23.9K
NEWT icon
2723
NewtekOne
NEWT
$370M
$90.7K ﹤0.01%
6,570
-3,294
-33% -$46.1K
HROW icon
2724
Harrow
HROW
$1.48B
$90.4K ﹤0.01%
8,073
+4,440
+122% +$52.5K
DYN icon
2725
Dyne Therapeutics
DYN
$4.85B
$90.4K ﹤0.01%
6,795
-1,194
-15% -$11.7K
107 108
109
110 111

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2023 Portfolio in Review

As of Q4 2023, Tower Research Capital (TRC) held 6,444 positions worth $8.1B, up 153% from $3.2B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $4.22B of net new capital in Q4 2023, opening 505 new positions and adding to 3,426 existing holdings. Its largest new stake was Veralto: 28,523 shares worth $2.35M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $21.7M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2023 buy was Veralto: 28,523 shares worth $2.35M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $314M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2023 reduction was iShares MSCI EAFE ETF, cutting an estimated $21.7M.
  • Tower Research Capital (TRC) fully exited Vanguard Morningstar Total Stock Market ETF in Q4 2023, selling an estimated $6.02M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $8.1B portfolio in Q4 2023.
  • Tower Research Capital (TRC) opened 505 new positions and closed 524 in Q4 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 153% quarter-over-quarter to $8.1B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.